• General anaesthesia with tracheal intubation is preferred as it ensures airway protection, adequate ventilation, and optimal conditions for the radiologist.
• Complications during the procedure include arrhythmias and haemorrhage due to vascular injury or liver capsule rupture.
• Early post-procedure complications include ventricular failure, encephalopathy, renal failure, liver failure, and sepsis.
Background
The prevalence of liver disease in the UK has increased substantially over recent decades, principally due to alcohol, nonalcoholic fatty liver disease associated with obesity, and viral hepatitis B and C. Liver cirrhosis may lead to the development of portal hypertension, which has a significant impact on patient outcomes and survival. These patients are clinically challenging and costly to manage, often requiring treatment for consequences of liver failure such as ascites, variceal haemorrhage, sepsis, and renal failure. Transjugular intrahepatic portosystemic shunt (TIPS) insertion offers a minimally invasive option for lowering raised portal pressure, which can provide symptomatic relief and confer a survival benefit in selected patients suffering the complications of portal hypertension. The first TIPS procedures were carried out in the 1980s, and success rates have increased as endovascular and radiological technologies have developed. There are, however, considerable challenges to delivering an effective TIPS service, including the organization of multidisciplinary input with appropriate anaesthetic expertise and support.
Portal hypertension
The liver receives ∼25% of the cardiac output, via a dual blood supply. The hepatic arteries carry oxygenated blood via the aorta and coeliac axis, while the portal vein carries nutrientrich blood from the gastrointestinal tract to process within the hepatic parenchyma. The portal vein is formed by union of the mesenteric veins and splenic vein posterior to the head of the pancreas, and divides into right and left branches which enter the respective liver lobes. Venous drainage is via the hepatic veins to the inferior vena cava.
Portal hypertension occurs when there is increased resistance to portal venous blood flow through the liver as a result of structural disruption, which can have many causes (Table 1) . The most common cause in the Western world, accounting for around 90% of cases, is liver cirrhosis. In addition to the fixed obstruction resulting from structural disruption, there can be a dynamic component due to stellate cell contraction within the liver as a result of acute events such as sepsis or acute high alcohol intake.
Diagnosis
The diagnosis of portal hypertension may be suspected clinically in patients with features of cirrhosis, suggestive haematology (thrombocytopenia), or diagnostic radiological findings (splenomegaly, recanalization of the umbilical vein, or reversal of flow in the portal vein). Diagnosis can be confirmed by measurement of the hepatic venous pressure gradient (HVPG), which is the gold standard for assessing portal hypertension and also has prognostic value. HVPG is a surrogate for the portal pressure gradient and is measured at hepatic venous catheterization as the difference between the balloon-wedged hepatic venous pressure and free hepatic venous pressure. Normal HVPG is up to 5 mm Hg; portal hypertension is defined as an HVPG ≥6 mm Hg, with clinical manifestations including variceal haemorrhage or liver decompensation typically occurring at ≥10 mm Hg as the increased portal venous pressure results in development of a collateral circulation. 1 Clinical manifestations of portal hypertension include ascites, hydrothorax (a transudative pleural effusion, on the right side in 90% of cases), varices (oesophageal, gastric, periumbilical, rectal), portal hypertensive gastropathy, hepatorenal syndrome, and hepatopulmonary syndrome. The physiological effects which result from the consequences of advanced liver disease and portal hypertension have been described in detail elsewhere. 2 
Treatment options
Treatment of portal hypertension aims to reduce HVPG either pharmacologically or by TIPS in order to manage these complications. In addition, treating the underlying cause, such as achieving abstinence from alcohol or using antiviral regimes, frequently limits or reverses complications.
Ascites and hepatic hydrothorax may respond to a sodium restricted diet or diuretics (e.g. spironolactone, furosemide) to promote sodium excretion. Diuretic-resistant ascites may require repeated large-volume paracentesis with i.v. albumin replacement.
In any patient with established cirrhosis, endoscopic surveillance for varices should be performed at diagnosis and repeated every 2-3 yr. Primary prophylaxis with non-selective β-block (e.g. carvedilol or propranolol) or endoscopic variceal band ligation is equally effective in reducing the risk of a first bleed. When medical or endoscopic therapy fails and portal pressure remains persistently high, shunt procedures such as TIPS may be beneficial.
Selection of patients for TIPS
TIPS provides symptomatic benefit and improves survival in patients with diuretic-resistant ascites which requires frequent paracentesis. 3 It confers a survival advantage when used for the control of variceal bleeding, 4 in which it can be used to control haemorrhage from oesophageal and gastric varices, and to prevent recurrence once initial control has been established. There are other uses for TIPS, which have limited supportive evidence ( Table 2 ). Clinical outcomes, including mortality, after TIPS can be predicted using liver disease severity scores such as the model for end-stage liver disease or Child-Pugh scores.
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There are several absolute and relative contraindications 6 (Table 3 ). Where possible, clinical assessment by a hepatologist, echocardiography, and triple-phase computed tomography (CT) should be performed in all patients.
Procedure and complications
TIPS insertion requires expertise in interventional radiology and is usually performed in the angiography suite. Internal jugular Hepatic venography (using contrast or carbon dioxide), often ultrasound-assisted by a second operator, is used to delineate the vascular anatomy of the liver and a communication between a branch of the hepatic venous and portal venous circulation is created by the cutting tip of the catheter under fluoroscopic control. After balloon dilatation of this communicating track, a polytetrafluoroethane-covered nitinol (e.g. Gore Viatorr®; typical dimensions 10 mm×80 mm) stent is deployed to maintain patency. Procedure duration varies and challenges include guidewire positioning and adequate HVPG reduction with stent placement; the objective is to reduce the HVPG to near normal levels and at a minimum to <12 mm Hg.
Internal jugular vein access can be complicated by carotid or tracheal puncture, pneumothorax or haemothorax, thoracic duct, or brachial plexus injury. The passage of the catheter through the right atrium may cause irritation precipitating arrhythmias, and rarely damage to the myocardium. Technical difficulty can occur in puncture of the portal vein, which may result in liver capsule puncture and potentially fatal haemorrhage into the peritoneal cavity. Portal venous rupture, inadvertent puncture of the hepatic arteries, biliary structures, and right kidney have also been reported. Late complications such as stent occlusion, thrombosis, or dislodgement may also occur. Major complications occur in 3-5% of procedures and mortality rates vary with the indication for TIPS, being higher for emergency procedures. 7 
Anaesthesia
Patients undergoing TIPS are medically complex as a result of chronic liver disease causing multisystem physiological disruption. They should receive multidisciplinary input as part of comprehensive preoperative assessment and optimization before undergoing the procedure.
Patients who are potential or confirmed transplant candidates must be carefully considered as TIPS may rarely precipitate sudden decompensation to fulminant hepatic failure. These cases should be discussed with a transplant centre and transferred if appropriate.
Pre-procedure work-up and optimization
A full evaluation of co-existing conditions should be undertaken in the usual manner before anaesthesia, although there are several particular areas to which attention must be directed in order to ensure optimal outcomes. The urgency of the procedure will determine the extent of preoperative work-up that is feasible.
Cardiovascular status must be assessed. Patients with cirrhosis often exhibit a hyperdynamic circulation with low-normal arterial pressure due to persistent splanchnic vasodilatation. Cardiac output will increase after TIPS insertion as pooled venous blood returns to the systemic circulation; hence, any degree of heart failure must be assessed before shunt insertion as this is likely to deteriorate with the effective fluid challenge postprocedure. Symptomatic heart failure and tricuspid regurgitation should be assessed using transthoracic echocardiography and treatment optimized before TIPS is considered. All patients should undergo echocardiography to determine left ventricular function and to exclude severe pulmonary hypertension; this would contraindicate the procedure due to the expected increase in right heart and pulmonary pressures with increased preload after shunting.
Reduced functional residual capacity due to ascites and hepatic hydrothorax impairs respiratory function. This is exacerbated by the supine position required for the procedure. Baseline ventilatory observations may reveal respiratory dysfunction, while a chest radiograph will indicate the presence and extent of hydrothorax. Consideration should be given to drainage of any intraperitoneal or intrathoracic fluid collection in patients with severe respiratory compromise. This is normally performed on the day before the TIPS procedure and should involve the use of albumin for volume replacement (8 g per 2.5 litres drained) to avoid post-paracentesis circulatory dysfunction and renal impairment.
Thrombocytopenia and coagulopathy are common in cirrhotic patients and these abnormalities should be corrected before shunt insertion. Targets are controversial; a platelet count more than 50×10 9 litre −1 and INR <1.5 are recommended in cases of gastrointestinal bleeding and are reasonable aims when considering TIPS. 8 Cross-matched blood should be requested according to local policy, bearing in mind that patients have often had multiple transfusions in the past after repeated variceal haemorrhage and may therefore have atypical antibodies requiring extended cross-matching and import of blood products from regional centres. In cases of variceal bleeding, a restrictive transfusion threshold (7 g dl −1 ) has been shown to improve outcomes in Child-Pugh class A or B patients, but not Child-Pugh C, when compared with a liberal transfusion threshold (9 g dl −1 ). 9 Baseline renal impairment must be investigated further, as this may represent intrinsic renal damage or a degree of hepatorenal syndrome. In either case, the receipt of a significant contrast load during TIPS insertion may adversely affect renal function. This may be attenuated by correction of hyponatraemia, volume expansion with human albumin solution, and the use of acetylcysteine for 48 h, although there is a lack of trial evidence to support this.
The presence and severity of hepatic encephalopathy should be assessed and graded, 2 as this may occur or worsen after shunt insertion due to entry of unprocessed portal blood into the systemic circulation. The presence of overt hepatic encephalopathy may contraindicate TIPS in the elective situation. In the emergency situation, such a detailed work-up is not feasible and the results of historical investigations may need to be acquired. Baseline laboratory testing should be performedhaemoglobin, platelet count, coagulation screen, and renal and hepatic function-as these will guide optimization and influence post-procedure destination. Haemodynamic stability should be the aim, but may be unattainable with ongoing variceal bleeding, and temporizing measures such as a Sengstaken tube insertion may have a place. I.V. fluid and blood product administration is required to maintain circulating volume and correct coagulopathy to an acceptable level for jugular and hepatic puncture. Patients with acute variceal haemorrhage will usually receive vasopressors (e.g. terlipressin) and broad-spectrum antibiotics (e.g. piptazobactam) as part of their medical therapy.
Anaesthetic technique
Complexities of remote site anaesthesia should be considered and include the delivery of care in an unfamiliar environment, often distant from theatres (and their inherent safety due to staff and equipment availability), with staff not necessarily trained in anaesthetic practice.
For elective TIPS procedures, the choice between sedation or general anaesthesia will depend on patient factors and local practice. There is little literature comparing different methods and so the advantages and disadvantages of each must be considered for each individual case.
Conscious sedation can be used, using combinations of shortacting sedative agents that include midazolam, propofol, and remifentanil. Although sedation may avoid the need for general anaesthesia, many patients experience significant discomfort in the supine position for a prolonged period of time. Airway protection is not guaranteed, ventilation may be compromised, agitation caused by encephalopathy may hinder safe completion of the procedure, and discomfort during balloon dilatation of the intrahepatic tracts may be severe. In cases managed under sedation, equipment and personnel should be immediately available for conversion to general anaesthesia, which may then present a significant challenge with a patient positioned on the imaging table.
General anaesthesia is recommended by many as the preferred technique on the grounds of safety, particularly when complications occur. 10 This requires the appropriate equipment, monitoring, and assistance as mandated by the AAGBI. Sedative premedication should be avoided, as this will have a prolonged effect, and may exacerbate encephalopathy. An H 2 -receptor antagonist or proton pump inhibitor can be used.
The logistics of anaesthetizing a patient in the interventional radiology suite will be dictated by the configuration of each individual angiography suite (an example is shown in Fig. 1 ). The induction of anaesthesia requires appropriate space and a tilting table in the case of regurgitation, and as this cannot be easily achieved on most angiographic tables, a separate location for induction and emergence from anaesthesia is sometimes required.
I.V. access should be secured, which may be difficult in the patient with chronic liver disease. Central venous access may be required, in which case the femoral veins or the left internal jugular vein can be used after discussion with the radiologist. Invasive arterial pressure monitoring should be used as haemodynamic instability is a frequent complication. Insertion of lines on the side most accessible to the anaesthetist in the interventional suite is advisable, along with the use of multi-lumen extension devices. A double pressure transducer is essential, as this will allow one port for connection of the arterial line and a second port for transduction of the venous pressure line inserted by the radiologist. Urinary catheterization and patient warming are required as procedures may be prolonged. A broad-spectrum antibiotic (e.g. piptazobactam or a third-generation cephalosporin) should be administered before the procedure and continued for 24 h after.
In most cases, tracheal intubation is the safest option, as patients with ascites have disrupted respiratory mechanics and a raised intra-abdominal pressure which will increase the risk of regurgitation of gastric contents. Rapid sequence induction of anaesthesia with application of cricoid pressure is often warranted. Controlled ventilation is useful as a motionless patient and the ability to provide frequent breath holds will aid the radiologist in positioning the shunt. Good communication between radiologist and anaesthetist is essential.
The choice of drugs demands consideration of the physiological and pharmacokinetic changes seen in chronic liver disease patients. 2 A cautious dose of propofol or thiopental is suitable for induction of anaesthesia, with muscle relaxation provided by succinylcholine followed by a renally excreted non-depolarizing neuromuscular blocking agent (e.g. atracurium). Short-acting opiates (e.g. alfentanil, fentanyl) can be used in carefully titrated doses to aid tube tolerance and cover stimulating parts of the procedure. Maintenance of anaesthesia with a volatile agent or a total i.v. anaesthesia technique is appropriate. 9 The aim should be to use appropriate doses of short-acting agents in order to allow rapid post-procedure recovery. Emergency TIPS for control of acute variceal haemorrhage is usually undertaken when endoscopic therapy has failed, or more commonly as a proactive early measure for those with Child-Pugh B with active bleeding or Child-Pugh up to C13. These patients are likely to possess a compromised airway, haemodynamic instability, coagulopathy, and susceptibility to sepsis and risk of hepatic encephalopathy. For acute haemorrhage, urgent stabilization will be required and measures may have already been instituted to facilitate endoscopic therapy. Airway protection by rapid sequence induction of anaesthesia and tracheal intubation is mandatory. Large-bore peripheral venous access and invasive arterial pressure monitoring will be required and correction of haematological abnormalities is essential, as is judicious blood transfusion. 8 It is not uncommon to require activation of a major haemorrhage pathway in this situation. For those patients undergoing TIPS after successful endoscopic therapy but with a high risk of re-bleeding, management principles can broadly follow the elective route. However, there may not be sufficient time to perform a full preoperative workup. The anaesthetist should be aware of an increased aspiration risk due to residual blood in the stomach, the potential for continued haemodynamic instability, and the effects of recent massive transfusion.
Post-procedure care
Haemodynamic instability may remain after the procedure in those with blood loss, so haemodynamic monitoring and correction of anaemia and coagulopathy is required. The increased venous return to the heart can precipitate heart failure, which will require initial medical stabilization followed by diuresis. The application of continuous positive airway pressure may also be considered in treating pulmonary oedema. A haemolytic anaemia may develop between 7 and 14 days post-procedure, due to mechanical shear stress on blood cells as they pass through the shunt.
Encephalopathy occurs in up to 20% of patients after TIPS. This can occur at any time after the procedure and is caused by shunting of hepatic venous blood containing neurophysiologically active compounds such as ammonia and benzodiazepine-like substances, which may enhance cerebral GABA-ergic tone. Hepatic encephalopathy can be managed with a combination of lactulose and non-absorbable antibiotics (e.g. rifaximin), TIPS shunt size reduction, or TIPS occlusion in intractable cases. 7 If iodine-based contrast is used, there is a risk of contrast nephropathy and an exacerbation of hepatorenal syndrome if this was present, even subclinically, before the procedure. Fluid management and renal replacement therapy should be considered in discussion with critical care and renal specialists.
There is a risk of post-procedural sepsis, principally caused by gram-negative organisms (e.g. Escherichia coli, Klebsiella, Enterococcus). Early identification and administration of antibiotics ( piptazobactam or a third-generation cephalosporin) is essential in order to avoid deterioration in organ function. Fluid and vasopressor therapy may be required.
Patients are managed either on critical care, hepatology, or gastroenterology wards and are subject to early warning scoring and frequent medical review. Given the potential for multisystem decompensation, access to critical care outreach and high dependency care in the post-procedure period is necessary. However, given the nature of the underlying disease and often guarded prognosis, escalation of care must be carefully considered with appropriate ceilings of care set in a multidisciplinary environment, ideally in advance of any intervention.
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